In exciting news for Alzheimer's patients and their families, the FDA plans to relax the rules for approving new treatments for the disease.

Dr. Gregg Shalan, a neurologist from Methodist Dallas Medical Center, joined News 8 at 5 Thursday to discuss what that decision means for those whose lives have been touched by Alzheimer's.

Read or Share this story: